Back

In patients surviving an ACS event, concomitant diabetes mellitus does not influence lipid lowering treatment - results from the dyslipidemia international study (DYSIS) II ACS

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Familial hypercholesterolemia and dyslipidaemia Epidemiology, lipids ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Dominik Lautsch

Merck Sharp & Dohme, Vienna, Austria; Am Europlatz 2, A-1120 Wien, Austria., Wien (Austria)

18 More presentations in this session

Presentation thumbnail
Screening for familial hypercholesterolemia in brazil: data from the study of cardiovascular risk in adolescents (ERICA study)
Doctor J. Faria Neto (Curitiba, BR)
Abstract Slides
Presentation thumbnail
Prognosis of patients with clinical familial hypercholesterolemia after acute coronary syndrome
Doctor D. Nanchen (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Heterozygous familial hypercholesterolaemia: a common entity with unfavorable long-term prognosis in patients with very early ST-segment elevation myocardial infarction
Professor L. Rallidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Clinical Impact of Heterozygous Carrier of ABCG5 Gene on Asymptomatic Normolipidemic Patients: Evidence from Familial Gene Analysis
Doctor H. Tada (Kanazawa, JP)
Abstract Slides
Presentation thumbnail
The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction
Ms S. Rerup (Copenhagen, DK)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Familial hypercholesterolemia and dyslipidaemia

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources